Published online May 1, 2008
PEDIATRICS Vol. 121 No. 5 May 2008, pp. e1229-e1239 (doi:10.1542/peds.2007-0871)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kapogiannis, B. G.
Right arrow Articles by Bulterys, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kapogiannis, B. G.
Right arrow Articles by Bulterys, M.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Human Immunodeficiency Virus...
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Trends in Bacteremia in the Pre- and Post-Highly Active Antiretroviral Therapy Era Among HIV-Infected Children in the US Perinatal AIDS Collaborative Transmission Study (1986–2004)

Bill G. Kapogiannis, MDa,b, Minn M. Soe, MD, MPHc, Steven R. Nesheim, MDa, Kevin M. Sullivan, PhD, MPHc, Elaine Abrams, MDd, John Farley, MD, MPHe, Paul Palumbo, MDf, Linda J. Koenig, PhDg and Marc Bulterys, MD, PhDg

Division of Infectious Diseases, Departments of a Pediatrics
b Medicine, Emory University School of Medicine
c Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
d Department of Pediatrics, Harlem Hospital Center, New York, New York
e Department of Pediatrics, University of Maryland, Baltimore, Maryland
f Department of Pediatrics, University of Medicine and Dentistry, Newark, New Jersey
g Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia

OBJECTIVE. HIV-infected children are at high risk for bacteremia. Highly active antiretroviral therapy has reduced rates of opportunistic infections; less is known about its effect on pediatric bacteremia rates. Thus, we sought to determine its impact on bacteremia incidence in HIV-infected children.

METHODS. Children born during 1986–1998 were followed until 2004 in the Perinatal AIDS Collaborative Transmission Study. We determined the pre–and post–highly active antiretroviral therapy (before and after January 1, 1997) incidence of bacteremia among HIV-infected children and characterized the CD4% temporal declines and mortality among patients with and those without incident bacteremias.

RESULTS. Among 364 children, 68 had 118 documented bacteremias, 97 before and 21 after January 1, 1997. Streptococcus pneumoniae constituted 56 (58%) pre–and 13 (62%) post–highly active antiretroviral therapy cases. The incidence rate ratio of bacteremias comparing post–versus pre–highly active antiretroviral therapy was 0.3 overall and 0.2, 0.2, and 0.4 among children aged 0 to 24, 25 to 48, and 49 to 72 months, respectively. Kaplan-Meier analysis for time to first bacteremia in children born during the pre–highly active antiretroviral therapy compared with the post–highly active antiretroviral therapy era revealed that 69% and 94%, respectively, remained bacteremia free at a median follow-up of 6 years. The Cox proportional hazards model also showed a significant reduction of bacteremias in the post–highly active antiretroviral therapy era, even after controlling for gender and race. Among children <6 years of age, those who experienced bacteremia had faster temporal CD4% decline than those who never had bacteremia. Survival analysis revealed that HIV-infected children with bacteremia experienced higher overall mortality when controlling for gender, race, and clinic site.

CONCLUSIONS. A significant decrease in bacteremia incidence and a prolongation in the time to first bacteremia incident were seen in the post–highly active antiretroviral therapy era. Children with a steeper decline of CD4 T cells were more likely to develop bacteremia. Children who experienced bacteremia had an associated higher mortality than their bacteremia-free counterparts.

Key Words: pediatric HIV/AIDS • bacteremia incidence • HAART

Abbreviations: OI—opportunistic infection • IVIG—intravenous immunoglobulin • PACTS—Perinatal AIDS Collaborative Transmission Study • CDC—Centers for Disease Control and Prevention • HOPE—HIV Follow-up of Perinatally Exposed Children • TMP-SMX—trimethoprim-sulfamethoxazole • CI—confidence interval

Accepted Oct 11, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?